0 0
Read Time:1 Minute, 59 Second

NEW DELHI, July 22, 2025 — A recent study warns that the escalating resistance to antibiotics is set not only to increase global mortality rates but also to more than double annual treatment costs—from $66billion today to a projected $159billion by 2050. The findings highlight antimicrobial resistance (AMR) as a major threat to global health and economic stability.

The Rising Cost of Superbugs

Experts from the Center for Global Development, led by policy fellow Anthony McDonnell, report that antibiotic-resistant bacteria—often termed “superbugs”—are the product of widespread misuse and overuse of antibiotics in healthcare and agriculture. As resistance spreads, infections become harder and more expensive to treat, increasing the number of hospital admissions and the length and intensity of stays. According to the study, treating resistant infections is roughly twice as costly as treating cases where antibiotics remain effective.

Global and Regional Impact

While all nations will bear the financial burden, the study notes that low- and lower-middle-income countries will be hit hardest. These regions are projected to experience the greatest increases in treatment costs and negative health outcomes.

Key findings include:

  • Projected annual direct health care costs of AMR increasing to $159billion by 2050.

  • AMR-related deaths expected to rise by 60% by 2050, leading to an estimated 38.5million fatalities between 2025 and 2050.

  • Global population growth would be 22.2million larger by 2050 if AMR-related deaths were eliminated.

Calls for Innovation and Action

The study urges immediate action to encourage innovation and ensure access to high-quality antibiotics. Improved stewardship, new drug development, and equitable access are deemed essential to stem the tide of resistance and avoid catastrophic impacts on global health systems.

“If resistance rates follow historical trends since 1990, the direct health care costs of AMR are projected to rise to $159billion per year by 2050 (1.2% of global health expenditure),” the researchers stated.

Disclaimer

This article is based on a report from the Center for Global Development as published by Eastern Mirror Nagaland. Projections and figures are drawn from current trends and are subject to change as new data emerges. The information provided does not constitute medical advice or financial forecasting and should be interpreted in the context of ongoing scientific research.

  1. https://www.easternmirrornagaland.com/antibiotic-resistance-to-drive-treatment-cost-from-66-bn-to-159-bn-yearly-by-2050-says-study
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %